Global Nasal Cannula Market By Type (High Flow Nasal Cannula and Low Flow Nasal Cannula), By Material (Silicone and Plastic), By End-Use (Hospitals, Long Term Care Centers, and Ambulatory Healthcare Services), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032
- Published date: Oct 2021
- Report ID: 16047
- Number of Pages: 201
- Format:
- keyboard_arrow_up
Nasal Cannula Market Overview:
Global nasal cannula sales were valued at USD 6,976.2 million in 2021. They are expected to grow at a CAGR of 5.7% between 2023 to 2032.
The rise in prevalence of the respiratory disease worldwide is a major factor that has contributed to the market’s growth. About 41% of all chronic respiratory diseases were responsible for the increase in morbidity, with asthma and COPD accounting for most of that.
Global Nasal Cannula Market Scope:
Type Analysis
The low flow was the dominant segment of the market, accounting for 65.1% of the total revenue in 2021. Low flow nasal cannulas are increasingly being used in long-term, home-care, and ambulatory settings, where patients are in stable states and require low or moderate concentration. Low cost and increased market share are two additional reasons why low-flow nasal cannulas are becoming more popular.
High flow nasal cannula is rapidly growing due to increased use of high flow nasal cannula for respiratory support in severely ill patients, and recent developments that allow high flow nasal cannula to be used in low-level healthcare settings.
Material Analysis
Plastic nasal cannulas dominated the market, accounting for 87.2% of the total revenue in 2021. This was due to their low cost and easy availability. They also provide greater comfort and flexibility to patients, even long-term users. The silicone-made nasal cannula, on the other hand, is slowly being adopted by long-term oxygen therapy patients, especially those who have experienced skin and nasal irritations and inflammations.
End-Use Analysis
The market was dominated by the hospital segment, which accounted for 47.1% of the total revenue in 2021. This is due to the increased use of high-flow nasal cannulas in severe respiratory distress. High flow oxygen signifies that the hospital has a higher market share in the end-use segment. The long-term care center segment of the nasal cannula market is expected to grow due to the increasing geriatric population as well as patients suffering from long-term respiratory distress.
Due to the growing geriatric population, the long-term care center market is expected to experience significant growth over the next few years. Long-term care centers will also be in demand due to an increase in long-term respiratory distress.
Key Market Segments:
By Type
- High Flow Nasal Cannula
- Low Flow Nasal Cannula
By Material
- Silicone
- Plastic
By End-use
- Hospitals
- Long Term Care Centers
- Ambulatory Healthcare Services
- Other End-uses
Market Dynamics:
Patients will be attracted to the country’s healthcare system by the increase in healthcare spending and the government’s initiatives for affordable healthcare. The market growth in the nasal cannula is also due to lifestyle changes, rising smokers, changing climatic conditions, and increasing air pollution.
Worldwide demand for nasal cannulas has also increased as a result of the current Covid-19 outbreak. Single-use nasal cannulas witnessed a rise in demand when the Centers for Disease Control and Prevention suggested high-flow nasal cannula oxygenation therapy as a routine treatment in the U.S.
The growing demand for and increased adoption of nasal cannulas is being addressed by a wide range of suppliers and manufacturers around the world. With their extensive distribution networks, the key players in the market have made it possible to offer technologically advanced products around the world.The nasal cannula has been developed as a silicone material. It is extra soft, latex-free, and curved. Flared nasal cannulas are also being used in chronic respiratory disease treatment. This has increased the use of nasal cannulas for patients of all ages. The market growth and adoption of nasal cannulas have been aided by the increasing availability of products via e-commerce.
Regional Analysis
North America was the dominant market for nasal cannulas and had the largest revenue share at 42.3% in 2021. This is due to an increase in respiratory diseases like asthma and COPD, which accounts for about 81% of all health care spending. The market for nasal cannula has seen a significant increase in adoption and low-cost products due to the expansion of international and local manufacturers.
Asia Pacific will be the fastest-growing market over the forecast period due to its high prevalence of COPD and asthma, as well as the increasing number of elderly people. The market is also growing due to rising healthcare spending and the increase in local manufacturers.
Key Regions and Countries covered іn thе rероrt:- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Russia
- Spain
- Rest of Europe
- APAC
- China
- Japan
- South Korea
- India
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- MEA
- GCC
- South Africa
- Israel
- Rest of MEA
Market Share & Key Players Analysis:
Global nasal cannula market growth is due to the rising prevalence of respiratory disease, the growing geriatric population, and increasing adoption. The current Covid 19 pandemic, which has seen high demand in many countries for nasal cannulas, has also led to increased production to meet this demand.
Research and development, as well as technological advancements by key players, have resulted in a nasal cannula that is more comfortable and flexible. This can be used to treat various conditions. A wide distribution network and growing e-commerce have made it possible to distribute the nasal cannula worldwide, which has led to increased market acceptance and growth.
Маrkеt Кеу Рlауеrѕ:
- Allied Healthcare Products, Inc.
- Flexicare Medical Ltd.
- Teleflex Incorporated
- ResMed Inc.
- Fisher & Paykel Healthcare Limited
- Vapotherm Inc.
- Salter Labs
- Well Lead Medical Co. Ltd.
- Fairmont Medical
- Other Key Players
For the Nasal Cannula Market research study, the following years have been considered to estimate the market size:
Attribute Report Details Historical Years
2016-2020
Base Year
2021
Estimated Year
2022
Short Term Projection Year
2028
Projected Year
2023
Long Term Projection Year
2032
Report Coverage
Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.
Regional Scope
North America, Europe, Asia-Pacific, South America, Middle East & Africa
Country Scope
United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa
Frequently Asked Questions (FAQ)
Q: What is the size of the Nasal Cannula market in 2021?A: The Nasal Cannula market size is US$ 6,976.2 million in 2021.
Q: What is the projected CAGR at which the Nasal Cannula market is expected to grow at?A: The Nasal Cannula market is expected to grow at a CAGR of 5.7% (2023-2032).
Q: List the segments encompassed in this report on the Nasal Cannula market?A: Market.US has segmented the Nasal Cannula market by geographic (North America, Europe, APAC, South America, and Middle East and Africa). By Type, market has been segmented into High Flow Nasal Cannula and Low Flow Nasal Cannula. By Material, market has been segmented into Silicone and Plastic. By End User, the market has been further divided into Hospitals, Long Term Care Centers, and Ambulatory Healthcare Services.
Q: List the key industry players of the Nasal Cannula market?A: Allied Healthcare Products, Inc., Flexicare Medical Ltd., Teleflex Incorporated, ResMed Inc., Fisher & Paykel Healthcare Limited, Vapotherm Inc., Salter Labs, Well Lead Medical Co. Ltd., Fairmont Medical, and Other Key Players engaged in the Nasal Cannula market.
Q: Which region is more appealing for vendors employed in the Nasal Cannula market?A: North America accounted for the highest revenue share of 42.3%. Therefore, the Nasal Cannula industry in North America is expected to garner significant business opportunities over the forecast period.
Q: Name the key areas of business for Nasal Cannula?A: The U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, Australia, Brazil, Mexico, South Africa, are key areas of operation for Nasal Cannula Market.
Q: Which segment accounts for the greatest market share in the Nasal Cannula industry?A: With respect to the Nasal Cannula industry, vendors can expect to leverage greater prospective business opportunities through the low flow nasal cannula segment, as this area of interest accounts for the largest market share.
- Allied Healthcare Products, Inc.
- Flexicare Medical Ltd.
- Teleflex Incorporated
- ResMed Inc.
- Fisher & Paykel Healthcare Limited
- Vapotherm Inc.
- Salter Labs
- Well Lead Medical Co. Ltd.
- Fairmont Medical
- Other Key Players
- settingsSettings
Our Clients
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |